Suppr超能文献

花生口服食物激发试验是否仍然有用?对疑似花生过敏、对Ara h 2致敏且患有可控哮喘的儿童的评估。

Are peanut oral food challenges still useful? An evaluation of children with suspected peanut allergy, sensitization to Ara h 2 and controlled asthma.

作者信息

Ojaniemi Iida, Salmivesi Susanna, Tikkakoski Antti, Karjalainen Jussi, Lehtimäki Lauri, Schultz Rüdiger

机构信息

Allergy Centre, Tampere University Hospital, PL 2000, 33521, Tampere, Finland.

Department of Clinical Physiology and Nuclear Medicine, Tampere University Hospital, Tampere, Finland.

出版信息

Allergy Asthma Clin Immunol. 2022 Nov 30;18(1):100. doi: 10.1186/s13223-022-00743-6.

Abstract

BACKGROUND

Sensitization to Ara h 2 has been proposed as a promising biological marker for the severity of peanut allergy and may reduce the need for oral food challenges. This study aimed to evaluate whether peanut oral food challenge is still a useful diagnostic tool for children with suspected peanut allergy and an elevated level of Ara h 2-specific IgE. Additionally, we assessed whether well-controlled asthma is an additional risk for severe reactions.

METHODS

A retrospective analysis of 107 children with sensitization to Ara h 2-specific IgE (> 0.35 kU/l) undergoing open peanut challenges during 2012-2018 in the Tampere University Hospital Allergy Centre, Finland.

RESULTS

Of the 107 challenges, 82 (77%) were positive. Serum levels of Ara h 2 -sIgE were higher in subjects with a positive challenge than in those who remained negative (median 32.9 (IQR 6.7-99.8) vs. 2.1 (IQR 1.0-4.9) kU/l), p < 0.001) but were not significantly different between subjects with and without anaphylaxis. No correlation was observed between the serum level of Ara h 2-sIgE and reaction severity grading. Well-controlled asthma did not affect the challenge outcome.

CONCLUSIONS

Elevated levels of Ara h 2-specific IgE are associated with a positive outcome in peanut challenges but not a reliable predictor of reaction severity. Additionally, well-controlled asthma is not a risk factor for severe reactions in peanut challenges in children with sensitization to Ara h 2.

摘要

背景

对Ara h 2致敏被认为是花生过敏严重程度的一个有前景的生物学标志物,可能会减少口服食物激发试验的需求。本研究旨在评估对于疑似花生过敏且Ara h 2特异性IgE水平升高的儿童,花生口服食物激发试验是否仍是一种有用的诊断工具。此外,我们评估了哮喘控制良好是否是严重反应的额外风险因素。

方法

对2012年至2018年在芬兰坦佩雷大学医院过敏中心接受开放性花生激发试验的107例对Ara h 2特异性IgE致敏(>0.35 kU/l)的儿童进行回顾性分析。

结果

在107次激发试验中,82次(77%)呈阳性。激发试验阳性的受试者血清中Ara h 2 -sIgE水平高于阴性受试者(中位数32.9(四分位间距6.7 - 99.8)对2.1(四分位间距1.0 - 4.9)kU/l),p<0.001),但有过敏反应和无过敏反应的受试者之间无显著差异。未观察到Ara h 2 -sIgE血清水平与反应严重程度分级之间的相关性。哮喘控制良好不影响激发试验结果。

结论

Ara h 2特异性IgE水平升高与花生激发试验阳性结果相关,但不是反应严重程度的可靠预测指标。此外,对于对Ara h 2致敏的儿童,哮喘控制良好不是花生激发试验中严重反应的风险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3c5/9714138/ebbaa05148ff/13223_2022_743_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验